Tue, November 25, 2014
Mon, November 24, 2014
Fri, November 21, 2014
Thu, November 20, 2014
Wed, November 19, 2014
Tue, November 18, 2014
Mon, November 17, 2014
Fri, November 14, 2014
Thu, November 13, 2014
Wed, November 12, 2014

Evan Seigerman Maintained (BIIB) at Buy with Decreased Target to $400 on, Nov 19th, 2014

Evan Seigerman of Credit Suisse, Maintained "Biogen Inc." (BIIB) at Buy with Decreased Target from $425 to $400 on, Nov 19th, 2014.

Evan has made no other calls on BIIB in the last 4 months.



There are 3 other peers that have a rating on BIIB. Out of the 3 peers that are also analyzing BIIB, 0 agree with Evan's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Evan


  • Brian Skorney of "Baird" Upgraded from Hold to Buy on, Wednesday, October 22nd, 2014
  • Christopher Marai of "Nomura" Maintained at Strong Buy with Increased Target to $424 on, Thursday, July 24th, 2014
  • Andrew Peters of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $430 on, Thursday, July 24th, 2014